Related Experiment Videos
Molecular cloning of a cDNA encoding canine factor IX
J P Evans1, H H Watzke, J L Ware
1Department of Medicine, UNC School of Medicine, Chapel Hill 27599.
Blood
|July 1, 1989
Summary
Researchers characterized the canine Factor IX (F.IX) gene, crucial for understanding hemophilia B in dogs. This genetic information aids in studying canine hemophilia B and developing gene therapies.
Area of Science:
- Molecular Biology
- Genetics
- Comparative Genomics
Background:
- Hemophilia B is a genetic bleeding disorder caused by deficiency of Factor IX (F.IX).
- A canine model of hemophilia B is available but requires detailed knowledge of normal canine F.IX structure for research.
- Understanding canine F.IX is essential for gene transfer studies and characterizing the disease in dogs.
Purpose of the Study:
- To isolate and characterize the coding region of the canine F.IX cDNA.
- To determine the complete coding sequence for canine F.IX.
- To provide a resource for studying canine hemophilia B and for gene therapy development.
Main Methods:
- Isolation and characterization of canine F.IX cDNA.
- Sequence analysis of the coding region.
- Comparative analysis with human F.IX.
Main Results:
- The complete coding sequence for canine F.IX was determined.
- Canine F.IX shows 86% amino acid identity with human F.IX.
- Key functional domains (leader peptide, Gla, EGF) and conserved residues for gamma-carboxylation were identified, showing high conservation between canine and human F.IX.
Conclusions:
- The determined canine F.IX sequence provides a valuable resource for hemophilia B research in dogs.
- This genetic information can aid in identifying the mutation causing hemophilia B in affected dogs.
- The canine F.IX clone is a potential tool for gene transfer experiments aimed at treating canine hemophilia B.